Question 1

Does Goldman Sachs own CRVS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs holds 1,576,352 shares of CRVS (Corvus Pharmaceuticals), worth $23.6M.

Question 2

How many shares of CRVS does Goldman Sachs own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs holds 1,576,352 shares of CRVS (Corvus Pharmaceuticals).

Question 3

What is Goldman Sachs' CRVS position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs' CRVS position is worth $23.6M.

Question 4

Is Goldman Sachs buying or selling CRVS?

Accepted Answer

In Q2 2026, Goldman Sachs increased its CRVS position by 35,543 shares (+2.3%).

Question 5

When did Goldman Sachs first buy CRVS?

Accepted Answer

Goldman Sachs already held CRVS in its Q2 2022 13F, the earliest on record, and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.6M	+2.3%	$23.6M	0.0%	$14.94	29
2026-Q1	Increased	1.5M	+178.5%	$22.5M	0.0%	$17.53	46
2025-Q4	Increased	553,327	+24.2%	$4.3M	0.0%	$7.49	33
2025-Q3	Increased	445,670	+161.8%	$3.3M	0.0%	$7.28	43
2025-Q2	Decreased	170,211	-53.8%	$680,844	0.0%	$3.89	0
2025-Q1	Decreased	368,318	-37.0%	$1.2M	0.0%	$3.38	0
2024-Q4	Increased	584,546	+55.4%	$3.1M	0.0%	$5.25	37
2024-Q3	New	376,121	-	$2M	0.0%	$5.15	36

CRVSShowing 8 of 14 quarters

CRVS
Showing 8 of 14 quarters